CS274285B2 - Method of substituted benzamides production - Google Patents

Method of substituted benzamides production Download PDF

Info

Publication number
CS274285B2
CS274285B2 CS960386A CS960386A CS274285B2 CS 274285 B2 CS274285 B2 CS 274285B2 CS 960386 A CS960386 A CS 960386A CS 960386 A CS960386 A CS 960386A CS 274285 B2 CS274285 B2 CS 274285B2
Authority
CS
Czechoslovakia
Prior art keywords
methoxy
amino
dihydro
product
filtered
Prior art date
Application number
CS960386A
Other languages
Czech (cs)
English (en)
Other versions
CS960386A2 (en
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Rennee Gardaix-Luthereau
Brenda Costall
Robert Naylor
Original Assignee
Doetudes Scient Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doetudes Scient Soc filed Critical Doetudes Scient Soc
Publication of CS960386A2 publication Critical patent/CS960386A2/cs
Publication of CS274285B2 publication Critical patent/CS274285B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CS960386A 1985-12-19 1986-12-19 Method of substituted benzamides production CS274285B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8518829A FR2592042B1 (fr) 1985-12-19 1985-12-19 Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
CS960386A2 CS960386A2 (en) 1990-09-12
CS274285B2 true CS274285B2 (en) 1991-04-11

Family

ID=9325965

Family Applications (1)

Application Number Title Priority Date Filing Date
CS960386A CS274285B2 (en) 1985-12-19 1986-12-19 Method of substituted benzamides production

Country Status (37)

Country Link
US (2) US4835172A (hu)
EP (1) EP0236646B1 (hu)
JP (1) JPS62246553A (hu)
KR (1) KR930004653B1 (hu)
CN (1) CN1018454B (hu)
AR (1) AR242193A1 (hu)
AT (1) ATE57376T1 (hu)
AU (1) AU586057B2 (hu)
CA (2) CA1298301C (hu)
CH (1) CH671396A5 (hu)
CS (1) CS274285B2 (hu)
DD (1) DD260495A5 (hu)
DE (2) DE3674916D1 (hu)
DK (1) DK612886A (hu)
ES (1) ES2036178T3 (hu)
FI (1) FI865190A (hu)
FR (1) FR2592042B1 (hu)
GB (1) GB2184723B (hu)
GR (1) GR3002524T3 (hu)
HU (1) HU196794B (hu)
IE (1) IE59212B1 (hu)
IL (1) IL81010A (hu)
IN (1) IN163130B (hu)
IS (1) IS1448B6 (hu)
MA (1) MA20835A1 (hu)
NO (1) NO168176C (hu)
NZ (1) NZ218675A (hu)
OA (1) OA08564A (hu)
PH (2) PH24365A (hu)
PL (1) PL148408B1 (hu)
PT (1) PT83982B (hu)
SU (1) SU1496632A3 (hu)
TN (1) TNSN86165A1 (hu)
YU (1) YU44796B (hu)
ZA (1) ZA869560B (hu)
ZM (1) ZM10686A1 (hu)
ZW (1) ZW24886A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295350B1 (fr) * 1987-06-17 1992-11-11 Laboratoires DELAGRANGE Application du N-[2-(diethylamino)ethyl]2-methoxy 4-[(1-H 4,5-dihydro-2-imidazolyl) amino]5-chloro benzamide comme anxiolytique et anti-psychotique
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US20050140688A1 (en) * 2003-12-29 2005-06-30 Kim Pallister Method and mechanism for programmable filtering of texture map data in 3D graphics subsystems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR1539104A (fr) * 1967-07-31 1968-09-13 Ile De France Nouveaux benzamides et leur procédé de préparation
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
DE1963193A1 (de) * 1969-12-17 1971-06-24 Bayer Ag N-substituierte 2-Arylimino-oxazolidine,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasiticide
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2905883A1 (de) * 1979-02-16 1980-08-28 Boehringer Sohn Ingelheim Radioimmuntest fuer clonidin
US4461904A (en) * 1981-11-20 1984-07-24 Alcon Laboratories, Inc. 2-(Trisubstituted phenylimino)-imidazolines
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS6341471A (ja) * 1986-08-08 1988-02-22 Nippon Soda Co Ltd オキサ(チア)ゾリジン誘導体、その製造法及び殺ダニ剤
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents

Also Published As

Publication number Publication date
DD260495A5 (de) 1988-09-28
PT83982A (en) 1987-01-01
PL263078A1 (en) 1988-04-14
NO168176C (no) 1992-01-22
ZA869560B (en) 1987-11-25
IL81010A (en) 1991-06-30
HU196794B (en) 1989-01-30
HUT43844A (en) 1987-12-28
OA08564A (fr) 1988-09-30
EP0236646B1 (fr) 1990-10-10
SU1496632A3 (ru) 1989-07-23
GB8630143D0 (en) 1987-01-28
AR242193A1 (es) 1993-03-31
AU586057B2 (en) 1989-06-29
YU44796B (en) 1991-02-28
GB2184723B (en) 1989-12-28
TNSN86165A1 (fr) 1990-01-01
NO865148D0 (no) 1986-12-18
KR930004653B1 (ko) 1993-06-02
FR2592042A1 (fr) 1987-06-26
NO865148L (no) 1987-06-22
ZW24886A1 (en) 1987-05-13
IS3178A7 (is) 1987-06-20
AU6668786A (en) 1987-06-25
IL81010A0 (en) 1987-03-31
EP0236646A1 (fr) 1987-09-16
CH671396A5 (hu) 1989-08-31
GR3002524T3 (en) 1993-01-25
NZ218675A (en) 1990-06-26
FI865190A0 (fi) 1986-12-18
DK612886D0 (da) 1986-12-18
ES2036178T3 (es) 1993-05-16
IS1448B6 (is) 1991-01-16
PH24469A (en) 1990-07-18
PT83982B (pt) 1989-01-17
JPS62246553A (ja) 1987-10-27
US4914117A (en) 1990-04-03
NO168176B (no) 1991-10-14
CA1299579C (fr) 1992-04-28
CN1018454B (zh) 1992-09-30
MA20835A1 (fr) 1987-07-01
DE3674916D1 (de) 1990-11-15
IN163130B (hu) 1988-08-13
FI865190A (fi) 1987-06-20
FR2592042B1 (fr) 1988-03-25
IE863270L (en) 1987-06-19
ZM10686A1 (en) 1987-11-27
CN86108972A (zh) 1987-11-18
KR870006008A (ko) 1987-07-08
YU217986A (en) 1987-12-31
IE59212B1 (en) 1994-01-26
ATE57376T1 (de) 1990-10-15
CA1298301C (fr) 1992-03-31
DE3643103A1 (de) 1987-06-25
US4835172A (en) 1989-05-30
PH24365A (en) 1990-06-13
CS960386A2 (en) 1990-09-12
GB2184723A (en) 1987-07-01
PL148408B1 (en) 1989-10-31
DK612886A (da) 1987-06-20

Similar Documents

Publication Publication Date Title
AT396685B (de) Verfahren zur herstellung von neuen 1,4-disubstituierten piperazinderivaten
US3586670A (en) Isothiocyanobenzazoles and use thereof as anthelmintics
US3843668A (en) Certain 4-substituted amino-2,1,3-benzothiadiozoles
CA2652074C (en) Substituted carboxamides as group 1 metabotropic receptor antagonists
US3704296A (en) Substituted thiazolidine-4-ones
HU192972B (en) Process for producing substituted phenyl-/sulfonyl-oxy/-benzimidazole-carbamate derivatives and pharmaceutical compositions containing them
US3725404A (en) 2-amino-4,4-di-substituted-4h-3,1-benzoxazines
DE1954584A1 (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
US4490527A (en) Benzo-fused heterocyclic anti-ulcer agents
CS274285B2 (en) Method of substituted benzamides production
US4046753A (en) Substituted 2-phenylhydrazino and 2-phenylazo thiazolines
DE2723464A1 (de) Aryltrifluoraethylamine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4289778A (en) 2-(Substituted imino)-N-(3-substituted phenyl)-3-thiazolidinecarbothioamides
DE2800062A1 (de) Benzokondensierte heterocyclische fuenfring, ihre herstellung und verwendung
FR2563519A1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
DE3213027A1 (de) 2,3-disubstituiertes 5,6-dihydroimidazo (2,1-b) thiazol, dessen salze, verfahren zu dessen bzw. deren herstellung und dieses bzw. diese enthaltendes entzuendungshemmendes mittel
DD258812A1 (de) Verfahren zur herstellung neuer ixoxazolderivate
EP0183190A1 (de) Benzamide und Salze
US3946010A (en) 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
DK171110B1 (da) Fremgangsmåde til fremstilling af 5-methyl-3-(2-pyridyl)-2H,5H-1,3-oxazino(5,6-c)-1,2-benzothiazin-2,4-(3H)-dion-6,6-dioxid eller farmaceutisk acceptable syreadditionssalte deraf
US5240918A (en) 2-(substituted imino)-thiazolidines and process for the preparation thereof
US4163105A (en) Aryloxymethyl imidazolines
JPS63275572A (ja) 1,5−ベンゾチアゼピン誘導体
EP0044266A2 (de) Neue substituierte 3,5-Diamino-1,2,4-oxadiazole und 3,5-Diamino-1,2,4-thiadiazole, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
US3975433A (en) 1-(2,4-Dimethoxy-phenyl)-3-(2-hydroxyethyl)thiourea